M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 5.56 EUR -2.46% Market Closed
Market Cap: 89.7m EUR

Operating Margin
Maat Pharma SA

-884%
Current
-908%
Average
-5.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-884%
=
Operating Profit
-28.4m
/
Revenue
3.2m

Operating Margin Across Competitors

Maat Pharma SA
Glance View

Market Cap
89.7m EUR
Industry
Biotechnology

Maat Pharma SA operates as a clinical-stage microbiome therapeutics company. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2021-11-08. The firm specializes in the microbiome therapy that is aimed to treatment of Gut Microbiota alteration (Dysbiosis) using patient-specific biotherapeutics in patients with serious medical conditions. Its MaaT Microbiome Restoration Therapy (MMRB) discovery and analysis platform supports the evaluation of drug candidates, the determination of new disease targets and the identification of biomarkers for microbiome-related conditions.

MAAT Intrinsic Value
13.89 EUR
Undervaluation 60%
Intrinsic Value
Price
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-884%
=
Operating Profit
-28.4m
/
Revenue
3.2m
What is the Operating Margin of Maat Pharma SA?

Based on Maat Pharma SA's most recent financial statements, the company has Operating Margin of -884%.

Back to Top